Stock BGNE BEIGENE, LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Relative Strength Chart BeiGene, Ltd.

Equities

BGNE

US07725L1026

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-24 pm EDT 		5-day change 1st Jan Change
152.7 USD -2.22% Intraday chart for BeiGene, Ltd. -11.65% -15.33%
May. 24 BeiGene Says Studies Highlight Effectiveness, Safety of Lymphoma Drug Brukinsa MT
May. 24 BeiGene, Ltd. Announces New Analyses for BRUKINSA® (zanubrutinib) At ASCO Underscore Differentiated Clinical Profile for Treatment of CLL and SLL CI

End-of-day quotes

Compared values

Sector Change 5d. change 1st Jan change 1-year change 5-years change Capi. ST MT LT
BEIGENE, LTD.
Bio Therapeutic Drugs
-2.22%-11.65%-15.33%-35.54%+20.61% 15.97B
Neutral
Neutral
Neutral
  1. Stock Market
  2. Equities
  3. BGNE Stock
  4. Charts BeiGene, Ltd.
  5. Relative Strength Chart